Join
Live feed
·
INSIDERFilingvia Quantisnow
Rubius Therapeutics Inc. logo

SEC Form 4: Keson-Brookes Maiken converted options into 8,075 shares and sold $17,957 worth of shares (2,732 units at $6.57) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RUBY (Rubius Therapeutics Inc.) and more on Quantisnow.